All posts by imreal

Palo Alto University Announces Opening of Mountain View Campus


“We are pleased to welcome Palo Alto University to the diverse and vibrant City of Mountain View,” says Mayor Lucas Ramirez. “As a member of our community, PAU will make mental health services more accessible and improve the quality of life for all residents.”

A ribbon cutting ceremony on November 10th at 11:00 a.m. will mark the Grand Opening of Palo Alto University’s (PAU) new Mountain View campus at 1172 Castro Street. The new campus facility will be home to PAU’s teaching and training clinics, the Gronowski Center, and PAU’s E-Clinic. Formerly located in Los Altos, the Gronowski Center offers sliding-scale in-person and tela-counseling psychotherapy services for adults, couples, and children. As well as two specialty clinics: La Clinica Latina and The Gender and Sexual Identities Clinic. In addition, the campus will also house classrooms, faculty, and administrative offices and be a hub for community workshops and events. The Mountain View Campus is one of two PAU campuses, with the other located on Arastradero Road in Palo Alto.

With ready access to transit services, the new location allows PAU’s training clinics to be more accessible for meeting the diverse mental health needs of the residents of Santa Clara and San Mateo County. It will also facilitate closer collaborations with important community partners based in Mountain View, including the Community Health Awareness Council (CHAC), Lifemoves, and many other agencies, hospitals, schools, and organizations.

“For nearly 50 years, PAU has served the mental health needs of the Bay Area and beyond as a leader in education, research, training, and clinical practice in the fields of psychology and counseling. We are thrilled to expand our reach and serve the diverse needs of the Mountain View community,” says PAU President Maureen O’Connor. “I am proud of the high-quality mental health care our faculty and students provide at the Gronowski Center and E-Clinic.”

“We are pleased to welcome Palo Alto University to the diverse and vibrant City of Mountain View,” says Mayor Lucas Ramirez. “As a member of our community, PAU will make mental health services more accessible and improve the quality of life for all residents.”

The grand opening event will feature a host of community leaders and a keynote address by Joe Farrow, President of the Board of the National Alliance of Mental Illness (NAMI), California chapter. Attendees will have the opportunity to tour the newly renovated facility.

Palo Alto University is grateful to the sponsors who helped lay a strong foundation for the Mountain View campus and for meeting the community’s mental health needs.

Master’s Level Sponsors

  • Intermountain Electric
  • Jorge Wong, PhD, Psychology and Consultation
  • Rodan Builders
  • SentinelOne and S Foundation

Bachelor’s Level Sponsors

  • Allen and Dorothy Calvin
  • Sand Hill Global Advisors
  • Santa Clara and San Mateo County Psychological Associations
  • Swinerton Management & Consulting
  • Vartain Law Group

Palo Alto University (PAU), a private, non-profit university located in the heart of Northern California’s Silicon Valley, is dedicated to addressing pressing and emerging issues in the fields of psychology and counseling that meet the needs of today’s diverse society. PAU offers undergraduate and graduate programs that are led by faculty who make significant contributions to their field. Online, hybrid, and residential program options are available. PAU was founded in 1975 as the Pacific Graduate School of Psychology and re-incorporated as Palo Alto University in August 2009. PAU is accredited by the Western Association of Schools and Colleges (WASC). PAU’s doctoral programs are accredited by the American Psychological Association (APA), and its master’s in counseling programs by the Council for Accreditation of Counseling & Related Educational Programs (CACREP).

Share article on social media or email:

CS Analytical Launches Educational Webinar Series on Container & Package System Qualification


News Image

As part of our ongoing commitment to industry engagement and education, the webinars are designed to share our experience and insight with clients and foster industry discussion on changing regulatory expectations and best practices.

CS Analytical Laboratory, the world’s only FDA regulated contract laboratory exclusively dedicated to providing regulatory solutions and qualification testing services specifically for drug product and medical device container systems is excited to announce that it will be launching an educational webinar initiative, with regularly scheduled presentations and Q&A discussions centered on key topics and trends in container and package system regulatory qualification. The first webinar is scheduled for Wednesday, December 7, 2022 at 10:00am through 11:30am EST and will cover “Comprehensive Container & Package System Qualification for Deep and Ultra-Cold Storage Products”. This initial webinar will be hosted by Brandon Zurawlow, Chief Scientific Officer for CS Analytical. These webinars are free of charge and attendees may register here.

“Over the past decade, the requirements for regulatory qualification of container and package systems have undergone numerous changes. CS Analytical has remained at the forefront of these developments,” commented CS Analytical CEO Brian Mulhall, “As part of our ongoing commitment to industry engagement and education, the webinars are designed to share our experience and insight with clients and foster industry discussion on changing regulatory expectations and best practices.”

In today’s marketplace, unique products such as cell and gene therapies, mRNA, and some viral vector vaccines are examples where storage temperatures below those of traditional drug products are often required. Package systems that will be holding, shipping and/or storing products at deep and ultra-cold temperatures (below -60° C) can introduce risk and challenges to the integrity of the primary package system due to changes to elastomer viscoelasticity and overall component shrinkage potential. This first webinar will present a clear review of relevant risks, regulatory considerations, and a defined roadmap for generating packaging data for cold storage systems in accordance with USP 1207 Container Closure Integrity and other industry best practices throughout all phases of the product lifecycle, from development to distribution. Key topics to be covered include:


  • Package Development
  • Compendial USP Tests
  • Non-compendial Tests
  • Dimensional Analysis
  • Capping Line Qualification
  • Residual Seal Force
  • USP 1207 Headspace
  • Method Validation
  • Transport Validation
  • Clinical Batch CCI
  • CCI on Stability
  • Control Strategies

Webinar attendees will gain valuable insight into how best to introduce a flexible and scalable program that will comprehensively characterize and address critical concerns for product manufacturers while mitigating risk to the product, business and most importantly, the patient.

About CS Analytical Laboratory

The only FDA regulated, cGMP laboratory dedicated exclusively to the complex world of drug and medical device container and package qualification testing, the CS Analytical Team includes the world’s leading experts on all relevant USP and EP requirements and thought leaders and pioneers on CCI (container closure integrity – CCI) testing. Offering a full suite of laboratory services to include all USP, EP and JP procedures specific to glass, plastic and elastomers as well as complete USP 1207 services that span basic feasibility studies, component qualification programs and advanced method development and validation for helium leak testing, vacuum decay, high voltage and headspace analysis leak testing. CS Analytical is the one source that can ensure your medical product container and package system meets the strict and complex regulatory requirements.

Share article on social media or email:

Global Wellness Summit Celebrates Industry Creators, Visionaries and Thought Leaders at an Impactful 16th Annual Conference in Tel Aviv


News Image

This year’s theme – Open Minds. Open Hearts. Open for Business. – reflected our desire to openly and honestly look at the wellness industry on a global scale and offer the kind of out-of-the-box thinking that helps leaders better envision the future for their businesses

The Global Wellness Summit (GWS), the most prestigious conference on the $4.4 trillion business of wellness, wrapped up yet another successful Summit in Tel Aviv last week. This year’s in-person conference attracted over four hundred delegates from the wellness, medical, scientific, tech, academic, hospitality and investment worlds to explore the dramatically different and bright future for wellness and preventative health that lies ahead. A photo gallery with highlights of the Summit can be viewed here, while the “Summit on Demand” Playlist is available for pre-order now.

“This year’s theme – Open Minds. Open Hearts. Open for Business. – reflected our desire to openly and honestly look at the wellness industry on a global scale and offer the kind of out-of-the-box thinking that helps leaders better envision the future for their businesses,” said Nancy Davis, GWS chief creative officer and executive director. “This year’s Global Wellness Award honorees, Shark Tank of Wellness finalists and Call for Innovation award winner represent this kind of thinking.”

Global Wellness Awards

This year, the Summit announced a new award, the Bennett Family Award for Collaboration in the Science of Wellness. Endowed and presented by Bija Bennett, YubiHealth chief wellness officer, the new award recognizes individuals working to merge science and wellness for the advancement of human health. Presented by Bennett, the award went to Professor Alon Chen, President of the Weizmann Institute of Science, and Juan de Pablo, Executive VP for Science, Innovation, National Laboratories and Global Initiatives at the University of Chicago. “This pair collaborated on research that will no doubt have significant implications for how wearables can powerfully influence the future of women’s health and help improve our understanding of the consequences of stress,” said Bennett when presenting the award.

The Leader in Innovation Award was presented to Rick Stollmeyer, founder of MindBody, by Josanna Gaither, Executive Director, Spa Channel & Education, Natura Bisse, the award sponsor. Stollmeyer created MindBody, the leading experience technology platform for the fitness, wellness, and beauty industries, in his garage, ultimately selling it for $1.9 billion. Stollmeyer emotionally accepted the honor saying, “This conference has helped remind me who I am and is truly changing the world. I’m honored to be part of it.”

“Turning abandoned railway tracks into an international destination was no small feat,” said GWS Advisory Board Member, Hannah Messerli, PhD, Economic Development Specialist, when honoring this year’s Leader in Sustainability. “What this visionary made possible, gives us all hope about how we might, in our own cities and towns, reimagine what public space is really all about, and what it was meant to be.” The award went to NYC High Line co-founder, Robert Hammond. Hammond is now turning his innovative thinking to urban wellness in his role as President & Chief Strategy Officer of Therme Group US.

Freddie Moross, Managing Director, myndstream, was the youngest award winner, receiving the Debra Simon Award for Leader in Furthering Mental Wellness. Presented by GWS Advisory Board Member, C. Victor Brick, CEO, Planet Fitness Growth Partners, LLC; Co- Founder, John W. Brick Mental Health Foundation, on behalf of Lauren Wright, Brick said of this next-generation wellness leader: “Not content to simply build his family’s extraordinary business—scoring major motion pictures and creating libraries of mindful music—Freddie has, instead, approached music as a tool for healing, a bridge to help people feel included and respected. His impact on neurodiverse communities, especially children, has already rippled through the wellness landscape and is destined to powerfully impact how we see and treat certain mental illness.”

The Leading Woman in Wellness Award went to industry luminary Sue Harmsworth, MBE, founder of one of the most iconic global spa brands, ESPA. Harmsworth spent five decades shaping the global spa, global wellness and beauty industries, responsible for designing 500+ spas in 65 countries and is an international legend who has received numerous awards and accolades. “Sue’s extraordinary vision and purpose has shaped the modern-day spa industry, something she continues to do to this day,” said Ömer Isvan, President of Servotel, presenting the award.

Shark Tank of Wellness Global Student Competition

Anvisha Vora, from Atlanta, Georgia’s Savannah College of Art and Design, took first place honors ($5,000) for Heare, a portable wand that uses micro-vibrations on targeted areas of the ear to manage mental well-being and stimulate the parasympathetic nervous system. Kay McCalla, also from the Savannah College of Art and Design, took second place honors ($3,000) with Aurb, an energetic art piece designed to elevate meditation with color therapy and healing crystals; while third place ($2,000) went to Cornell University’s David Austin Jones for Sol Sauna, a floating sauna business concept that will bring a true sauna experience to urban hotspots and natural settings across the United States.

The Shark Tank of Wellness awards were presented by Frank Pitsikalis, Vice President, Strategy at Agilysys; and founder of ResortSuite and fellow judges Amir Alroy, co-founder of Welltech Ventures; Karen Campbell, Business Development Consultant, Chiva-Som International Health Resort; and Aldina Duarte Ramos, Global Director of Well-Being at ACCOR.

Call for Innovation: Wellness & the Metaverse

This year’s Call for Innovation focused on wellness and its place in the metaverse. Seven finalists from seven countries (chosen from seventy applicants) were invited to present their innovations to a powerful lineup of judges virtually and in-person at Meta’s offices in Tel Aviv, Israel. The winner, Virtuleap, a health and education startup with a mission to elevate cognitive assessment and training using virtual reality and artificial intelligence, took home the award, which was presented by Amir Alroy, Co-Founder, Welltech Ventures. Virtuleap CEO and Co-founder Amir Bozorgzadeh accepted the award, explaining the evolution of their technology involving game developers and neuroscientists working side by side. The award was co-sponsored by Welltech Ventures and Meta in Israel.

To pre-order the Summit on Demand Playlist, click here.

About the Global Wellness Summit —The Global Wellness Summit is the premier organization that brings together leaders and visionaries to positively shape the future of the $4.4 trillion global wellness economy. Its future-focused conference is held at a different global location each year and has traveled to the United States, Switzerland, Turkey, Bali, India, Morocco, Mexico, Austria, Italy, Singapore, and Israel. GWS also hosts other virtual and in-person gatherings, including Wellness Master Classes, Wellness Sector Spotlights, Investor “Reverse Pitch” events and Global Wellness Symposiums. The organization’s annual Global Wellness Trends Report offers expert-based predictions on the future of wellness. The 2023 Summit will be held in Doha, Qatar.

Mount Sinai Beth Israel Recognized by the American College of Surgeons National Surgical Quality Improvement Program for Meritorious Outcomes in Surgical Patient Care


“It is incredibly rewarding to see the hard work of the dedicated teams at Mount Sinai Beth Israel who are the driving force behind this distinction.” – Jeremy Boal, MD, President of Mount Sinai Beth Israel and Downtown

The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) has recognized Mount Sinai Beth Israel for achieving meritorious outcomes for surgical patient care in 2021. Mount Sinai Beth Israel is one of 78 hospitals to achieve this honor out of an eligible 607 hospitals that participate in the program.

ACS NSQIP-participating hospitals are required to track the outcomes of inpatient and outpatient surgical procedures; these outcomes are then analyzed by ACS and reported back to hospitals. These results inform patient safety initiatives within the hospital and impact the quality of surgical care for all patients.

“It is incredibly rewarding to see the hard work of the dedicated teams at Mount Sinai Beth Israel who are the driving force behind this distinction,” said Jeremy Boal, MD, President of Mount Sinai Beth Israel and Downtown. “The innovative surgical and medical care powered by the extraordinary research at the Icahn School of Medicine at Mount Sinai is advancing health and striving to provide equitable care for the patients, families, and communities we serve.”

The ACS NSQIP recognition program commends a select group of hospitals for achieving a meritorious composite score in either an “All Cases” category or a category which includes only “High Risk” surgical cases. Each composite score was determined through a different weighted formula combining eight potential adverse outcomes. Outcomes in the following eight clinical areas were evaluated:


  • Mortality
  • Cardiac arrest and myocardial infarction
  • Pneumonia
  • Unplanned intubation
  • Ventilator use for more than 48 hours
  • Renal failure
  • Surgical site infection (SSI): superficial incisional SSI, deep incisional SSI, and organ/space SSI
  • Urinary tract infection

“The hospitals on our meritorious lists are demonstrating a real commitment to using data to improve the surgical care they provide their patients. They deserve special recognition for their commitment to quality improvement,” said Clifford Y. Ko, MD, MS, MSHS, FACS, FASCRS, Director of the ACS Division of Research and Optimal Patient Care. “ACS NSQIP is the only nationally validated quality improvement program that measures and enhances the care of surgical patients. By examining its data related to other hospitals, a hospital can readily identify areas where they need to improve and put action plans in place to do it.”

About the American College of Surgeons

The American College of Surgeons is a scientific and educational organization of surgeons that was founded in 1913 to raise the standards of surgical practice and improve the quality of care for all surgical patients. The College is dedicated to the ethical and competent practice of surgery. Its achievements have significantly influenced the course of scientific surgery in America and have established it as an important advocate for all surgical patients. The College has more than 84,000 members and is the largest organization of surgeons in the world. “FACS” designates that a surgeon is a Fellow of the American College of Surgeons.

About the Mount Sinai Health System

Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.

Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report’s Best Hospitals, receiving high “Honor Roll” status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children’s Hospital among the country’s best in several pediatric specialties. The Icahn School of Medicine at Mount Sinai is one of three medical schools that have earned distinction by multiple indicators: It is consistently ranked in the top 20 by U.S. News & World Report’s “Best Medical Schools,” aligned with a U.S. News & World Report “Honor Roll” Hospital, and top 20 in the nation for National Institutes of Health funding and top 5 in the nation for numerous basic and clinical research areas. Newsweek’s “World’s Best Smart Hospitals” ranks The Mount Sinai Hospital as No. 1 in New York City and in the top five globally, and Mount Sinai Morningside in the top 30 globally; Newsweek also ranks The Mount Sinai Hospital highly in 11 specialties in “World’s Best Specialized Hospitals,” and in “America’s Best Physical Rehabilitation Centers.”

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

Share article on social media or email:

Brevi-T Introduces a Bold New Weapon in the Fight Against the Deadly Drug Crisis


News Image

“Brevi-T’s PULSE system is an epidemiological approach, testing at the large groups level and tracking that use over time. This allows entities to identify whether their solutions are working in real time and allows for more intelligent targeted testing where merited.” Paul Scott, Brevi-T Bio, CTO

Brevi-T Bio today announced its pioneering drug abuse monitoring, assessment, and evaluation system. The first-of-its-kind ecosystem and action plan for public health management solves the major problems associated with accurately identifying the presence, type, and scale of drug use.

There is growing concern over the introduction and proliferation of new and even more deadly Drugs of Abuse. To respond rapidly to a crisis in its early stages, it’s essential to have real-time warnings when drug use patterns are shifting.

Unfortunately, significant challenges exist with the tracking of drugs, largely because of the limitations of flawed drug use reporting. Drug use is generally conducted privately and unofficially, and is largely confidential and undisclosed, but the data on which drug consumption trends are based typically rely on self-reporting by the drug users themselves. Consequently, methods used to identify the prevalence of drug abuse, such as population surveys, crime statistics, and medical records, depend on the honesty of the respondent and may not reveal the true picture and problem.

Further, there is usually a long lag before results from surveys are available to view, sometimes years later. Imprecise and slow data mean that the police, public health officials, researchers, educators, parents, and even drug users don’t know what risks are lurking until it’s too late.

Wastewater analysis is a proven, non-intrusive, anonymous, and cost-efficient method of gathering objective and reliable data on drug use in a community, district, school, or workplace. The results are not subject to respondent bias and reveal a more accurate and truthful picture of the drugs being consumed.

Timely and reliable data on the scale, type, and demographics of illegal drug use is essential to understand drug consumption patterns, identify or improve action plans and procedures, and to ensure the maximum reduction of adverse – and often lethal – effects of drug abuse.

For the first time ever, Brevi-T introduces PULSE, a centralized database with standardized collection and testing methods, environmental demographics, packaged in a user-friendly interface. The breakthrough single source solution precisely aggregates, interprets, and compares real-time data for a wide range of substances in a single panel.

In addition to identifying a broad range of amphetamines, barbiturates, opioids, and stimulants, PULSE analyzes patterns, predicts trends, and provides vital context for decision-makers, arming them with accurate information to assist with the implementation of strategies aimed at addiction intervention, prevention, treatment, and recovery.

The ability to spot trends is crucial for decision makers to evaluate the efficacy of their drug prevention programs and make changes if they aren’t delivering expected results. Brevi-T’s single source approach will help implementers identify specific drugs that may be causing a pandemic amongst their populations, and zero in on the specific drug so they can execute an action plan to help save lives.

State-of-the-art cloud-based software integrates automated wastewater testing, individual swab testing (if required), data enrichment, advanced analytics, rapid reporting, and a real-time alert system to deliver accurate drug prevalence results. Additionally, PULSE provides consistent and automated sample process management and logistics through its mobile apps, which is critically important for identifying factors that may result in false positives or false negatives.

The PULSE dashboard interface presents vital information clearly and easily accessible, allowing users with no technical experience to quickly understand results, and accelerate their life-saving work in preventing and eradicating one of today’s most devastating health crises.

“The opioid epidemic has been a problem in this country for decades and the medical system, based on one-at-a-time testing, has not provided a solution,” said Paul Scott, CEO of Avrok Biosciences, and CTO of Brevi-T Bio. “Brevi-T’s PULSE system is an epidemiological approach, testing at the large groups level and tracking that use over time. This allows entities, both private and public, to identify whether their solutions are working in real time and allows for more intelligent targeted testing where merited.”

About Brevi-T Bio

Brevi-T, a joint venture between InterOme, a digital health enterprise, and Avrok Biosciences is tackling some of the world’s biggest public health challenges, including infectious diseases, substance abuse, and environmental contaminants through improved practices, plans and policies. Brevi-T’s mission is to make the world a healthier place, by creating the means to detect, assess, and manage public health risk factors to prevent the spread of epidemics. Brevi-T’s goal is to use actionable data for the best possible individual and public health outcomes.

For additional information, please visit https://www.brevitbio.com

InHome Therapy Acquires Libertas Rehab to Grow Its Community of Therapists in Texas


InHome Therapy, a network of physical, occupational, and speech therapists who work in patients’ home settings, continues to grow and expand its reach. The company finalized an acquisition deal with Texas-based Libertas Rehab at the end of August.

Libertas Rehab is a home therapy concept serving the metro areas of Corpus Christi, San Antonio, Austin, El Paso, Dallas, Fort Worth, and Houston. The business was created in 2014 by Martin Salazar III, Joseph Banlasan, and Jose Salvador, who together had a combined 55 years of experience in healthcare and wanted to bring quality care to people’s homes.

Over their eight years in business, they grew Libertas Rehab to a network of about 200 therapists who conduct an average of 60,000 patient visits annually. This acquisition of providers and guests is a big step in InHome Therapy’s continued expansion.

“We were interested in them because acquiring their brand has enabled us to further expand in the Texas market. We are now in areas that we weren’t in prior because they have a very broad coverage area within the state,” said Rick Anglin, InHome Therapy’s Corporate Development Officer. “We’re excited because their relationships will enable us to grow into other markets as well.”

Salazar, Banlasan, and Salvador, who are joining on as managing partners, are excited to now operate under the InHome Therapy name. Joining a bigger brand affords them many opportunities on a broader scale.

When the founders decided they wanted to sell the business, they did a great deal of due diligence to vet the approximately 60 companies interested in acquiring Libertas Rehab. InHome Therapy was a promising fit and “a good partnership from the start,” Banlasan said.

“I’m very excited for our staff because of the possibilities this opens up for them: stability of work, benefits, professional growth, help with continuing education and things like that,” said Banlasan. “Many of our therapists have been with us from the start, and they’re happy to hear we’re under a bigger umbrella now.”

Taking care of their therapists has always been hugely important to the men, because “if the therapist is cared for, the patient is going to receive quality care,” Salazar said.

The brand is excited to have them stay on as an integral part of the business, Anglin said.

“With these three, we have acquired some very talented management. They understand the business, have great work ethics and had a culture very similar to ours, where everything is centered around the therapist,” Anglin said. “They’re very much devoted to growing and expanding our business. It’s been a great match.”

About InHome Therapy

InHome Therapy leverages its unmatched systems, processes, and tools to unlock a new approach for delivering sustainable and measurable results to home therapy patient care, ensuring that patients, agencies, and therapists rise together. Today InHome Therapy employs hundreds of therapists and has completed over 2 million patient visits in key locations across the country, utilizing powerful and easy-to-use tools and training that allow therapists to continuously deliver optimal care. For more information, visit http://www.inhometherapy.com.

Share article on social media or email:

Thought Technology Ltd to Showcase MyOnyx Rehab Solution for Continence Training at Medica Trade Fair


biofeedback, sEMG, continence training

MyOnyx Rehab Solution

The company is looking to engage with international industry leaders to create synergies and collaborations.

Thought Technology will be demonstrating its MyOnyx rehab device at Medica Trade Fair November 14-17, 2022, in Dusseldorf, Germany (Hall 16J44). Developed for the rehab market, the MyOnyx rehab solution features a sleek hand-held device, equipped with two surface electromyography (sEMG) sensors that measure and display muscle activity in real time. For use in continence training, it is coupled with a vaginal or rectal sensor and pressure sensors, it provides feedback that helps the rehab professional ensure the activation of the specific muscles being targeted for treatment. Both patient and therapist can see when exercises are performed correctly and efficiently. In addition, one of it’s four stimulation sensors can be used for electrical stimulation o f vaginal/rectal sensors.

Urinary and fecal incontinence are very common disabling syndromes that can severely impact quality of life and wellbeing. Population-based studies have shown that urinary incontinence ranges between 2% and 25% in adults and that it is three times more common in women than in men. The prevalence of fecal incontinence ranges between 2% and 20% in the adult population and it equally affects men and women. It is frequently prescribed pre and post childbirth or prostatectomy surgery. Incontinence can severely impact lifestyle forcing sufferers to withdraw from day-to-day physical activity.

The MyOnyx rehab solution features training screens specifically designed for pelvic floor muscle rehabilitation. During the training sessions, the patient is guided by a bargraph or a tone to contract/relax the pelvic floor muscles (PFM) throughout a series of exercises, including tense/relax and quick flicks. As with any muscle being trained, this increases the size of the PFM, strengthens its tone at rest and heightens awareness of its contraction.

A powerful tool for continence training, the MyOnyx system can be used for single or dual site muscle rehabilitation protocols. When muscle activity is greatly reduced, due to partial paralysis, EMG triggered electrostimulation is an effective technique to help restore strength and movement control. The MyOnyx provides 2 channels of STIM/ EMG triggered STIM and 4 channels of electrostimulation options, including NMES.

MyOnyx is also a great tool for patient follow-up and outcome measurement. Users can download EMG biofeedback sessions (RMS) to the Android app and use it to review the data and print out statistical reports. It can be connected to a PC to easily access raw EMG data and generate session and trend reports – essential tools for documenting session work and tracking progress.

Asked about their continence training product line, Helen Mavros, Sales and Marketing Director, replied, “A significant segment of the population will experience incontinence at some point in their lives. The MyOnyx rehab solution takes continence training to the next level by helping clinicians provide targeted training, while helping their clients learn to perform training exercises more effectively. It’s really about helping people regain confidence and restoring their freedom to do the things they love.”

Thought Technology also offers a U-Control® Home Trainer. It’s perfect for clients who want to accelerate their rehabilitation with additional training sessions or to periodically reinforce their successful clinical training at home.

About Thought Technology Ltd.

Founded in 1975, Thought Technology is the world’s leading biofeedback and physiological instrument manufacturer. Its products are used as an essential part of many therapeutic treatments and clinical assessment protocols in over 85 countries and are used by tens of thousands of clinicians in thousands of medical institutions.

Always supportive of new research and development ideas, Thought Technology Ltd. has encouraged a number of special interest groups and clinicians to create cutting edge applications for its instrumentation. Thought Technology Ltd. equipment is now being used in telemedicine, web-based monitoring and biofeedback, sports training, research in human-machine interface, physiology-driven multimedia environments and virtual reality. Constantly striving to improve the quality of the products and services, TTL has obtained, and maintains, ISO 13485, and CE certification for the organization and products.

Share article on social media or email:

Alley Cat Rescue Letter Endorsing Trap-Neuter-Return for Outdoor Cat Population Management Gains Support From Over 160 Cat Experts Around the Globe


tabby cat in catio enclosure

Cat enjoying the outdoors within enclosure

We agree that outdoor cat populations need to be controlled. Nonlethal humane methods exist and we have over 30 years of proof that they work effectively.

In reaction to the Polish Academy of Sciences’ recent classification of domestic cats (Felis catus) as an “invasive alien species,” Alley Cat Rescue (ACR) has penned an open letter to environmental leaders of multiple Island and other nations, urging them to reject any policies that promote cat culling and to manage feral cat populations through the nonlethal practice of Trap-Neuter-Return (TNR).

Over 160 veterinarians, animal welfare groups, and other cat professionals signed in support of the letter, which has been sent to the heads of the economic departments of Australia, Brazil, Cayman Islands, Dominican Republic, Galapagos Islands, Haiti, Iceland, Indonesia, Ireland, Jamaica, Japan, Mauritius, New Zealand, Papua New Guinea, Philippines, Singapore, Slovakia, Sri Lanka, Trinidad and Tobago, and the USA. These countries were selected due to their unique wildlife, which some conservationists believe are threatened by feral cat predation.

Alley Cat Rescue President and Founder, Louise Holton, explains the group’s motivation behind the letter, saying “We agree that outdoor cat populations need to be controlled. Nonlethal humane methods exist and we have over 30 years of proof that they work effectively, And what other methods are offered? Snaring, poisoning, shooting, bludgeoning them to death. Is this the way to treat any animal, let alone the cat, beloved by many all across the world?”

ACR argues, through historical examples and scientific studies, that eradication is less effective and more costly than TNR. The cat advocacy organization also uses historical evidence to reveal common unintended consequences of eradicating cats from an enclosed ecosystem. ACR points to Marion Island as one example, where cats were culled in order to protect sea birds. Cats were killed off over a 19-year-long campaign, resulting in an explosion in the mice population. The mice turned to preying on sea bird chicks, proving the campaign to be an expensive failure.

The full letter and list of signers is available on Alley Cat Rescue’s website at http://www.saveacat.org/tnr-support-letter.html.

Alley Cat Rescue is a national nonprofit organization dedicated to the welfare of all cats: domestic, stray, abandoned, and feral. ACR advocates for humane nonlethal control of feral cats. For more information, visit their website http://www.saveacat.org.

Share article on social media or email:

Plant-based Athletes Will Be Running in Record Numbers at the 2023 Austin Marathon


New York Times bestselling author and PLANTSTRONG founder Rip Esselstyn is launching a new training program geared for plant-based athletes.

New York Times bestselling author and PLANTSTRONG founder Rip Esselstyn is launching a new training program geared for plant-based athletes.

“People think it’s hard to change. Do you know what’s hard? Heart Disease. Type II Diabetes. High cholesterol is hard. We’re raising awareness that you can fuel an active lifestyle by eating the world’s strongest nutrition: plants,” Rip Esselstyn explains the idea behind launching TEAM PLANTSTRONG.

Despite the medical community making headway in the fight against cancer, conditions like obesity, high blood pressure, and heart disease, are still on the rise. As a result, doctors are just beginning to preach what Rip Essselstyn, New York Times bestselling author and former top triathlete, has dedicated his life to – helping people understand there is a low-cost way to reach optimal health: eat your fruits and veggies and get outside and move!

“People think it’s hard to change the way they fuel their bodies. But do you know what I think is hard? Heart Disease. Type II Diabetes is hard. Hypertension and high cholesterol are hard. We want to raise awareness that you can fuel an active lifestyle, ward off chronic diseases, and feel your absolute best by eating the world’s strongest nutrition: plants,” Rip explains on his acclaimed show, The PLANTSTRONG Podcast.

In 2009, Rip established PLANTSTRONG, a community dedicated to helping the average American discover the benefits of a whole food plant-based diet. And while millions have already been helped, PLANTSTRONG is taking it up another notch by launching TEAM PLANTSTRONG, a community dedicated to fitness in addition to celebrating the benefits of plant-based eating.

With high-profile runners like 7x Ironman Carrie Barrett already signed up as the captain, the TEAM is taking its message of “PLANTSTRONG Performance” to the streets of Austin by bright green TEAM shirts. An official partnership with the Austin Marathon will also place a focus on the new TEAM’s mission and message.

“We couldn’t be more excited to have PLANTSTRONG join our TEAM program and showcase their products at our health & fitness expo this year. We wholeheartedly support a healthier lifestyle of plant-based whole foods and look forward to celebrating with all of them at the finish line in 2023,” explained Jack Murray, founder of the Austin Marathon.

It’s not just for runners. Anybody can join TEAM PLANTSTRONG, whether you are running, walking, or just cheering others along. The all-inclusive, everybody-welcome attitude that PLANTSTRONG has always embodied will extend to this TEAM as well.

The TEAM offers a complete training support program led by PLANTSTRONG Coach Carrie Barrett, an accomplished triathlete and ultra distance runner. “It doesn’t matter whether you are training for a 5k, half, or full marathon, TEAM PLANTSTRONG is your best bet to discovering the power of plants and showcasing your lifestyle to others. I can’t wait to meet everyone in Austin,” Coach Barrett shared.

FOR MORE INFORMATION:

ABOUT PLANTSTRONG: At PLANTSTRONG, we advocate for the scientifically proven benefits of plant-based living. We envision a world that universally understands, promotes and prescribes plants as the solution to empowering health, enhancing performance, and restoring the environment.

TEAM PLANTSTRONG Website: https://plantstrongfoods.com/pages/team-plantstrong

Dropbox link for photos: https://www.dropbox.com/scl/fo/kpokggsa6pgx5c7rf6q3s/h?dl=0&rlkey=49d3tm17rzw0pwcz0n7hn5oj4

Interview or review unit requests please contact Laurie Kortowich.

Share article on social media or email:

dicentra’s Hala Mousa Joins the Board of Directors for the Natural Health Product Research Society of Canada (NHPRS)


News Image

“I’m thrilled with the opportunity to work with the NHPRS and continue to be an advocate for quality research. I hope this collaboration between the NHPRS and dicentra will aid the advancement of health and wellness by collaborating with industry leaders and sharing knowledge with others.”

dicentra, a leading Contract Research Organization (CRO) and global consulting firm for the life sciences and food industries, is pleased to announce that Hala Mousa, dicentra’s CRO Operations Lead, has joined the Board of Directors for the Natural Health Product Research Society of Canada (NHPRS).

The mission of the NHPRS is to promote scientifically rigorous research and education on Natural Health Products (NHP’s). Its Board of Directors is comprised of NHP experts from both academia and private organizations across Canada. The Board of Directors aims to find consensus amongst a number of organizational goals such as the development of a national research community, planning activities and events, and increasing and promoting Canada’s capacity for NHP research, among others.

With over two decades of experience consulting clients on the natural health products regulations (NHPR), dicentra has a wealth of expertise and knowledge in the NHP industry. In 2019, dicentra expanded its services by creating a Clinical Trials division, which has seen exceptional growth since its inception. “Clinical Research is our quickest growing division, thanks in part to the contributions of Hala, who is our CRO Operations Lead,” says Peter Wojewnik, Partner at dicentra. “She is extremely capable, as she has proven over her past 2 years at dicentra. We know she’ll be a great addition to the Board of Directors at the NHPRS. Well done, Hala!”

Hala’s appointment to the Board of Directors of the NHPRS marks the latest collaboration between the NHPRS and dicentra, a relationship that has been ongoing since the NHPRS’s inception in 2003. “We’ve been involved with the NHPRS for almost as long as we’ve been a company,” says Peter Wojewnik. “We’ve attended many of their annual conferences, participating and giving presentations since the early 2000’s”.

With Hala Mousa now on the Board of the NHP Research Society of Canada, dicentra hopes to share its knowledge and expertise in both the NHP industry and the clinical trial industry in helping the NHPRS with its mission “to promote scientifically rigorous research and education on natural health products (NHPs)”.

“Natural Health Product research has been a personal passion and driving force for my career for many years,” says Hala Mousa, CRO Operations Lead and new Board member at the NHPRS. “I’m thrilled with the opportunity to work with the NHPRS and continue to be an advocate for quality research. I hope this collaboration between the NHPRS and dicentra will aid the advancement of health and wellness by collaborating with industry leaders and sharing knowledge with others.”

“We are happy to have Hala join us.” Says Pierre Haddad, President of the NHPRS. “It will be an exciting year for the NHPRS with the added and valuable input of Hala!”

About dicentra

dicentra is a leading Contract Research Organization (CRO) and global consulting firm that specializes in addressing all matters related to safety, quality, and compliance for all product categories in the life sciences and food industries. We evaluate, implement, and provide all the necessary support for products and operations to gain market access and build confidence in your brand. We achieve this through our three business divisions: consulting, clinical trials, and certifications. Since our inception in 2002, we have completed over 24,000 projects and serviced over 1,400 companies internationally. https://dicentra.com/

About NHP Research Society of Canada

The Natural Health Product Research Society of Canada is a federally incorporated non-profit organization founded in 2003 by a collaboration of academic, industry, and government researchers from across Canada. Its mission is to promote scientifically rigorous research and education on natural health products (NHPs), develop a national multi-sector research community, and support national research priorities that enable the informed and appropriate use of NHPs. https://www.nhprs.ca/

dicentra, un organisme de recherche sous contrat (ORC) de premier plan et une entreprise d’experts-conseils internationale pour les industries des sciences de la vie et de l’alimentation, est fier d’annoncer la nomination de Hala Mousa, Directrice des opérations de dicentra, au Conseil d’administration (CA) de la Société canadienne de recherche sur les produits de santé naturels (SCRPSN).

La mission de la NHPRS est de promouvoir une recherche et une éducation scientifiquement rigoureuses sur les produits de santé naturels (PSN). Son conseil d’administration est composé d’experts en PSN provenant des milieux académique et industriel. Le conseil d’administration vise à établir un consensus sur un nombre d’objectifs de l’organisation, tels que le développement d’une communauté de recherche nationale, la planification d’activités et d’événements, ainsi que l’augmentation et la promotion de la capacité de recherche du Canada en matière de PSN, entre autres.

Avec plus de deux décennies d’expérience à conseiller ses clients en matière réglementaire sur les PSN, dicentra possède de nombreuses connaissances et une grande expertise dans le domaine de l’industrie des PSN. En 2019, dicentra a élargi son offre de services en créant la division des essais cliniques qui a connu une croissance fulgurante depuis sa création. “La recherche clinique est notre division quiconnait la croissance la plus rapide, en bonne partie grâce au leadership de Hala, notre Chef des opérations”, affirme Peter Wojewnik, associé chez de dicentra. “Elle est extrêmement compétente, ce qu’elle a su prouver lors de ses deux dernières années chez dicentra. Nous sommes convaincus qu’elle sera un excellent atout pour le conseil d’administration de la SCRPSN. Bravo Hala!”

La nomination de Hala au CA de la SCRPSN représente la toute dernière collaboration entre la SCRPSN et dicentra, alors que la relation entre les deux entités date depuis la création de la SCRPSN en 2003. “Nous collaborons avec la SCRPSN depuis presque aussi longtemps que nous sommes une entreprise”, déclare Peter Wojewnik. “Nous avons assisté à bon nombre de leurs conférences annuelles, en participant et en donnant des présentations depuis le début des années 2000”.

Avec la venue de Hala au sein du conseil d’administration de la SCRPSN, dicentra espère partager ses connaissances et son expertise, tant dans l’industrie des PSN que dans celle des essais cliniques, afin d’aider la SCRPSN à remplir sa mission, qui est de “promouvoir la recherche scientifique rigoureuse et l’éducation en matière de produits de santé naturels (PSN)”.

“La recherche sur les PSN est une passion pour moi et le moteur de ma carrière depuis de nombreuses années,” partage Hala Mousa, Chef des opérations de l’ORC et nouveau membre du conseil d’administration de la SCRPSN. “Je suis ravie d’avoir l’opportunité de travailler avec la SCRPSN et de continuer de militer pour la recherche de qualité. J’espère que ce resserrement de la relation entre la SCRPSN et dicentra contribuera au progrès en matière de santé et de mieux-être, grâce à une collaboration avec les leaders de l’industrie et au partage de nos connaissances avec d’autres.”

“Nous sommes très heureux que Hala se joigne à nous,” se réjouit Pierre Haddad, Président de la SCRPSN. “Ce sera une année passionnante pour la Société avec la contribution précieuse de Hala!”

À propos de dicentra

dicentra est un organisme de recherche sous contrat (ORC) de premier plan et une entreprise d’experts-conseils internationale, spécialisée dans le traitement de toutes les questions liées à l’innocuité, à la qualité et à la conformité pour toutes les catégories de produits dans les secteurs des sciences de la vie et de l’alimentation. Nous évaluons, mettons en œuvre et fournissons tout le soutien nécessaire relativement aux produits et aux opérations afin de faciliter l’accès au marché et de renforcer la confiance en votre marque. Nous y parvenons grâce à nos trois divisions commerciales, soit la consultation, les essais cliniques et les certifications. Depuis notre fondation en 2002, nous avons réalisé plus de 24 000 projets et fourni des services à plus de 1 400 entreprises à l’échelle internationale. https://dicentra.com/

À propos de la Société canadienne de recherche sur les PSN

La Société canadienne de recherche sur les produits de santé naturels est un organisme à but non lucratif constitué en vertu d’une loi fédérale en 2003 par un regroupement de chercheurs universitaires, industriels et gouvernementaux à travers le Canada. Sa mission est de promouvoir la recherche scientifique rigoureuse et l’éducation en matière de produits de santé naturels (PSN), de développer une communauté nationale de recherche multisectorielle et d’appuyer les priorités de recherche à l’échelle nationale, qui permettent une utilisation éclairée et appropriée des PSN. https://www.nhprs.ca/fr/